Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03089495
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
FEB | N~2~-[(3R)-3-hydroxydodecanoyl]- L-asparaginyl-N~1~-[(1S)-1-(hydroxymethyl)- 3-methylbutyl]-L-glutamamide | 2,H,K,N,V,Y | 3D29 | 0.82 | |
ATI | N-(3-AMINO-2-HYDROXY-5-METHYLHEXANOYL)VALYLVALYLASPARTIC ACID | A | 1Y0Y | 0.78 | |
AR9 | (2R,4S)-N-butyl-4-[(2S,5S,7R)-2,7- dimethyl-3,15-dioxo-1,4-diazacyclopentadecan- 5-yl]-4-hydroxy-2-methylbutanamide | A,B,C | 3DV1 | 0.82 | |
IVS | 3-HYDROXY-6-METHYL-4-(3-METHYL- 2-(3-METHYL-2-(3-METHYL-BUTYRYLAMINO)- BUTYRYLAMINO)-BUTYRYLAMINO)-HEPTANOIC ACID ETHYL ESTER | A,B | 1ME6 | 0.87 | |
ABX | 5-[1-(ACETYLAMINO)-3-METHYLBUTYL]- 4-(METHOXYCARBONYL)PROLINE | A | 1XOE | 0.73 | |
REY | GLYCYL-L-ALPHA-AMINO-EPSILON-PIMELYL- D-ALANINE | A | 1IKI | 0.73 | |
AFJ | (2R,4S,5S)-N-butyl-4-hydroxy-2,7- dimethyl-5-{[N-(4-methylpentanoyl)- L-methionyl]amino}octanamide | A,B,C | 3DUY | 0.72 | |
76V | N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN- 2-YL]CARBONYL}-L-ISOLEUCYL-L-ISOLEUCINE | A | 2DCB | 0.73 | |
2NC | N-{(2S)-2-[(N-acetyl-L-threonyl- L-isoleucyl)amino]hexyl}-L-norleucyl- L-glutaminyl-L-argininamide | A,B | 3BVA | 0.72 | |
074 | [PROPYLAMINO-3-HYDROXY-BUTAN-1,4- DIONYL]-ISOLEUCYL-PROLINE | A | 1QDQ | 0.74 | |
SB1 | (21S)-1AZA-4,4-DIMETHYL-6,19-DIOXA- 2,3,7,20-TETRAOXOBICYCLO[19.4.0] PENTACOSANE | A,B | 1FKI | 0.7 | |
75V | N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN- 2-YL]CARBONYL}-L-ISOLEUCYL-L-ALANINE | A | 2DCA | 0.71 | |
CYV | ETHYL (4R)-4-{[(2R,5S)-5-{[N-(TERT- BUTOXYCARBONYL)-L-SERYL]AMINO}- 6-METHYL-2-(3-METHYLBUT-2-EN-1- YL)-4-OXOHEPTANOYL]AMINO}-5-[(3R)- 2-OXOPYRROLIDIN-3-YL]PENTANOATE | A | 2QIQ | 0.76 | |
TMD | (6,7-DIHYDRO)4-[(E)-BUTENYL]-4,N- DIMETHYL-THREONINE | C | 1CWK | 0.77 | |
U17 | METHYL N-[(2S,3R)-3-AMINO-2-HYDROXYHEPTANOYL]- L-SERYL-L-LEUCINATE | A | 2GGB | 0.86 | |
DH9 | (2S,3S,5S)-5-[(N-FORMYL-L-LEUCYL)OXY]- 2-HEXYL-3-HYDROXYHEXADECANOIC ACID | A,B | 2PX6 | 0.81 | |
PCJ | (2R)-3-{[(2S)-3-HYDROXY-2-(PALMITOYLAMINO)PROPYL]THIO}PROPANE- 1,2-DIYL DIHEXADECANOATE | A,N | 2Z81 | 0.71 | |
PCJ | (2R)-3-{[(2S)-3-HYDROXY-2-(PALMITOYLAMINO)PROPYL]THIO}PROPANE- 1,2-DIYL DIHEXADECANOATE | A,B,C | 2Z7X | 0.71 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A | 3EMY | 0.9 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A | 2H6T | 0.9 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,B | 1LS5 | 0.9 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,B | 1SME | 0.9 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,C | 1W6I | 0.9 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,B | 1XDH | 0.9 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,B | 2QZX | 0.9 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A | 1IZE | 0.9 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,B | 1M43 | 0.9 | |
EPX | EPOXOMICIN | D,F,G,H,I,K, L,N,Y | 1G65 | 0.81 | |
AMK | (S)-4-AMINO-4-{(S)-1-[(S)-2-CARBAMOYL- 1-((S)-1-{(S)-[(1R,2R)-2-((S)-1- CARBOXY-ETHYLCARBAMOYL)-CYCLOPENTYL]- HYDROXY-METHYL}-3-METHYL-BUTYLCARBAMOYL)- ETHYLCARBAMOYL]-2-METHYL-PROPYLCARBAMOYL}- BUTYRIC ACID | A,B,C | 1YM4 | 0.78 | |
RO4 | [[1-[N-HYDROXY-ACETAMIDYL]-3-METHYL- BUTYL]-CARBONYL-LEUCINYL]-ALANINE ETHYL ESTER | A | 2TCL | 0.73 | |
74M | METHYL N-({(2S,3S)-3-[(PROPYLAMINO)CARBONYL]OXIRAN- 2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINATE | A | 2DC9 | 0.71 | |
REZ | (2R)-2-AMINO-7-{[(1R)-1-CARBOXYETHYL]AMINO}- 7-OXOHEPTANOIC ACID | A,B | 2J9P | 0.71 | |
REZ | (2R)-2-AMINO-7-{[(1R)-1-CARBOXYETHYL]AMINO}- 7-OXOHEPTANOIC ACID | A,B,C,D | 2VGK | 0.71 | |
ITL | (3alpha,5alpha,8alpha)-3-[(N,N- bis{2-[bis(carboxymethyl)amino]ethyl}- L-gamma-glutamyl)amino]cholan-24- oic acid | A | 2K62 | 0.7 | |
2G0 | (2S)-1-[(2S)-6-amino-2-({[(2S,3S,4R,5S,6S)- 3,4,5-trihydroxy-6-methyltetrahydro- 2H-pyran-2-yl]acetyl}amino)hexanoyl]- N-[(1S)-1-carbamoyl-3-methylbutyl]pyrrolidine- 2-carboxamide | A,B,C,D | 3DCQ | 0.75 | |
S80 | N1-HYDROXY-2-(3-HYDROXY-PROPYL)- 3-ISOBUTYL-N4-[1-(2-METHOXY-ETHYL)- 2-OXO-AZEPAN-3-YL]-SUCCINAMIDE | A,B | 1BIW | 0.75 | |
U0E | N-[[1-[N-ACETAMIDYL]-[1-CYCLOHEXYLMETHYL- 2-HYDROXY-4-ISOPROPYL]-BUT-4-YL]- CARBONYL]-GLUTAMINYL-ARGINYL-AMIDE | B | 1GNO | 0.72 | |
U0E | N-[[1-[N-ACETAMIDYL]-[1-CYCLOHEXYLMETHYL- 2-HYDROXY-4-ISOPROPYL]-BUT-4-YL]- CARBONYL]-GLUTAMINYL-ARGINYL-AMIDE | B | 1A9M | 0.72 | |
U0E | N-[[1-[N-ACETAMIDYL]-[1-CYCLOHEXYLMETHYL- 2-HYDROXY-4-ISOPROPYL]-BUT-4-YL]- CARBONYL]-GLUTAMINYL-ARGINYL-AMIDE | A | 1AXA | 0.72 | |
U0E | N-[[1-[N-ACETAMIDYL]-[1-CYCLOHEXYLMETHYL- 2-HYDROXY-4-ISOPROPYL]-BUT-4-YL]- CARBONYL]-GLUTAMINYL-ARGINYL-AMIDE | A | 1GNM | 0.72 | |
U0E | N-[[1-[N-ACETAMIDYL]-[1-CYCLOHEXYLMETHYL- 2-HYDROXY-4-ISOPROPYL]-BUT-4-YL]- CARBONYL]-GLUTAMINYL-ARGINYL-AMIDE | A | 1GNN | 0.72 | |
AUA | A,B,C | 1YM2 | 0.7 | ||
EP2 | methyl N-[(2S)-4-{[(1S)-1-{[(2S)- 2-carboxypyrrolidin-1-yl]carbonyl}- 3-methylbutyl]amino}-2-hydroxy- 4-oxobutanoyl]-L-leucylglycylglycinate | B | 1SP4 | 0.76 | |
042 | N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN- 2-YL]CARBONYL}-L-THREONYL-L-ISOLEUCINE | A | 2DC7 | 0.74 | |
E6C | N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO- 2-METHYL-BUTANE | A | 1PPP | 0.72 | |
E6C | N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO- 2-METHYL-BUTANE | A | 1PE6 | 0.72 | |
E6C | N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO- 2-METHYL-BUTANE | A | 1ITO | 0.72 | |
5FE | 5,5,5-TRIFLUORO-3-HYDROXY-4-[2- (5,5,5-TRIFLUORO-3-HYDROXY-4-{3- METHYL-2-[3-METHYL-2-(3-METHYL- BUTYRYLAMINO)-BUTYRYLAMINO]-BUTYRYLAMINO}- PENTANOYLAMINO)-PROPIONYLAMINO]- PENTANOIC ACID METHYL ESTER | A,B | 1XE5 | 0.77 | |
EOV | A,B | 3EOV | 0.75 | ||
LNT | N-[(2S)-2-amino-1,1-dihydroxy-4- methylpentyl]-L-threonine | A,B,C | 3B80 | 0.71 | |
LNT | N-[(2S)-2-amino-1,1-dihydroxy-4- methylpentyl]-L-threonine | A,B,C | 3B7V | 0.71 | |
SCV | N6-[(1S)-2-{[(1R)-1-CARBOXY-2-METHYLPROPYL]OXY}- 1-(MERCAPTOCARBONYL)-2-OXOETHYL]- 6-OXO-L-LYSINE | A | 1HB2 | 0.72 | |
SCV | N6-[(1S)-2-{[(1R)-1-CARBOXY-2-METHYLPROPYL]OXY}- 1-(MERCAPTOCARBONYL)-2-OXOETHYL]- 6-OXO-L-LYSINE | A | 1HB4 | 0.72 | |
SCV | N6-[(1S)-2-{[(1R)-1-CARBOXY-2-METHYLPROPYL]OXY}- 1-(MERCAPTOCARBONYL)-2-OXOETHYL]- 6-OXO-L-LYSINE | A | 1HB3 | 0.72 | |
097 | (2S,3R)-N~4~-[(1S)-2,2-dimethyl- 1-(methylcarbamoyl)propyl]-N~1~,2- dihydroxy-3-(2-methylpropyl)butanediamide | A,B | 3HY7 | 0.71 | |
097 | (2S,3R)-N~4~-[(1S)-2,2-dimethyl- 1-(methylcarbamoyl)propyl]-N~1~,2- dihydroxy-3-(2-methylpropyl)butanediamide | A,B | 2JIH | 0.71 | |
097 | (2S,3R)-N~4~-[(1S)-2,2-dimethyl- 1-(methylcarbamoyl)propyl]-N~1~,2- dihydroxy-3-(2-methylpropyl)butanediamide | A | 1R55 | 0.71 | |
LP4 | (R)-((2R,3S,4R,5S)-2-(HYDROXYMETHYL)- 5-((R)-3-HYDROXYTETRADECANAMIDO)- 3-(PHOSPHONOOXY)TETRAHYDRO-2H-PYRAN- 4-YL) 3-HYDROXYTETRADECANOATE | A | 2E59 | 0.72 | |
5FP | 5,5,5-TRIFLUORO-3-HYDROXY-4-[2- (5,5,5-TRIFLUORO-3-HYDROXY-4-{3- METHYL-2-[3-METHYL-2-(3-METHYL- BUTYRYLAMINO)-BUTYRYLAMINO]-BUTYRYLAMINO}- PENTANOYLAMINO)-PROPIONYLAMINO]- PENTANOIC ACID | A,B | 1XE6 | 0.76 | |
BB2 | ACTINONIN | A,B,C,D | 3G5K | 0.74 | |
BB2 | ACTINONIN | A,B,C | 1LRU | 0.74 | |
BB2 | ACTINONIN | A,B | 2OKL | 0.74 | |
BB2 | ACTINONIN | A | 2OS1 | 0.74 | |
BB2 | ACTINONIN | A,B,C | 1G2A | 0.74 | |
BB2 | ACTINONIN | A | 1Q1Y | 0.74 | |
BB2 | ACTINONIN | A,B,C,D,E,F, G,H | 1SZZ | 0.74 | |
BB2 | ACTINONIN | A | 1LQY | 0.74 | |
BB2 | ACTINONIN | A | 2OS3 | 0.74 | |
BB2 | ACTINONIN | A | 1LRY | 0.74 | |
BB2 | ACTINONIN | A,B | 1IX1 | 0.74 | |
BB2 | ACTINONIN | A | 1WS1 | 0.74 | |
REX | GLYCYL-L-ALPHA-AMINO-EPSILON-PIMELYL- D-ALANYL-D-ALANINE | A | 1IKG | 0.74 |